This Vaccine Maker Can ‘Dominate’ The Covid Market For Years To Come, Wells Fargo Predicts
Topline Wall Street is underestimating vaccine maker Pfizer, which is primed for massive growth ahead as its Covid treatments will remain relevant for years—not to mention generate billions of dollars of revenue for the company, according to analysts at Wells Fargo. Although its shares have lagged that of other vaccine makers in 2021, Pfizer could …